ACM
FOLD

Aquatic Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Aquatic Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-72,094
Closed -$568K – 1521
2025
Q3 		$568K Sell
72,094
-177,902
-71% -$1.27M 0.01% 836
2025
Q2 		$1.43M Buy
249,996
+59,912
+32% +$387K 0.03% 559
2025
Q1 		$1.55M Sell
190,084
-45,330
-19% -$419K 0.04% 479
2024
Q4 		$2.22M Buy
235,414
+157,214
+201% +$1.63M 0.06% 356
2024
Q3 		$835K Buy
78,200
+34,500
+79% +$376K 0.02% 533
2024
Q2 		$434K Sell
43,700
-69,200
-61% -$710K 0.02% 575
2024
Q1 		$1.33M Buy
+112,900
New +$1.44M 0.04% 335
2023
Q4 		– Sell
-42,400
Closed -$516K – 1429
2023
Q3 		$516K Buy
+42,400
New +$547K 0.02% 476
2023
Q2 		– Sell
-36,400
Closed -$404K – 1473
2023
Q1 		$404K Buy
36,400
+20,000
+122% +$247K 0.03% 456
2022
Q4 		$200K Buy
+16,400
New +$185K 0.01% 732
2022
Q2 		– Sell
-1,100
Closed -$10K – 1316
2022
Q1 		$10K Buy
+1,100
New +$10.3K 0.01% 658

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aquatic Capital Management's FOLD Position: Q4 2025 in Review

Aquatic Capital Management sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 72,094 shares — an estimated $568K sold.

Aquatic Capital Management first reported a position in FOLD in Q1 2022 and held it in 11 quarters. The position peaked at $2.22M in Q4 2024. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • Aquatic Capital Management reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 72,094 Amicus Therapeutics shares in Q4 2025, an estimated $568K.
  • Aquatic Capital Management first reported a position in Amicus Therapeutics in Q1 2022 and held it in 11 quarters.
  • Aquatic Capital Management's Amicus Therapeutics position peaked at $2.22M in Q4 2024.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on Aquatic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.